Melanoma analyses link mutation subtypes to distinct tumor immune signatures
Source check: Source checked. Not independent scientific confirmation.
Finding: Cross-cohort AI analysis linked melanoma mutation subtypes to distinct immune landscapes and implicated CCNE1; cell-line knockdown provided functional support.
Technology: Machine learning survival models, including regularized regression and tree-based methods
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The study compared learned survival models to identify an inflammatory signature and nominate CCNE1 from melanoma datasets.
- Test and result
- Four expression cohorts plus cell-line functional validation; retrospective data and in-vitro support do not establish treatment efficacy.
- Limitation / still unknown
- The four-cohort analyses and cell-line knockdown do not establish treatment efficacy in patients.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/#methods · https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/#results
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.